InstaPill partners with Aché to expand access to ODT solutions across Latin America
InstaPill has announced its strategic partnership with Aché Laboratórios Farmacêuticos S.A. (Aché) to co-develop the first of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
SPDS hosts Dissolution Science Programme for FDA inspectors
The Society for Pharmaceutical Dissolution Science (SPDS) conducted a highly interactive value-adding programme on Dissolution…
US FDA conclude Lupin’s Nagpur Unit-1 facility inspection with zero observation
Lupin announced that the United States Food and Drug Administration (US FDA) has completed a product specific Pre-Approval…
AI in pharma: Disruption, displacement, and a new digital dawn
Dr Rajendra Pratap Gupta, Chairman of the Academy of Digital Health Sciences and Former Advisor to the Health Minister of India,…
Kyasanur Forest Disease – How far is a regulatory approved vaccine?
Dr Priyabrata Pattnaik, Former Deputy MD, Indian Immunologicals, informs about the Kyasanur Forest Disease (KFD), a zoonotic viral…
India to host CPHI & PMEC India 2025 from 25–27 November at India Expo Mart, Greater Noida
Event organised by Informa Markets in India to bring over 2,000 exhibitors and 50,000 industry participants from more than 120…
ENTOD Pharmaceuticals supports National Myopia Week 2025 with nationwide awareness campaign
The initiative aims to expand preventive education, screenings, and community engagement across 450 districts in India
Pfizer completes acquisition of Metsera for USD 7 billion to expand obesity and cardiometabolic…
The deal adds multiple clinical-stage candidates, including GLP-1 and amylin assets, as Metsera becomes a wholly owned Pfizer…
Lupin launches Risperidone extended-release injectable suspension in the U.S. with 180-day CGT…
The launch marks Lupin’s first product using PrecisionSphereTM, the long-acting injectable platform developed by Nanomi B.V.
Zydus Lifesciences receives USFDA approval for Diroximel Fumarate delayed-release capsules
The approval covers the treatment of relapsing forms of multiple sclerosis in adults, with production to take place at Zydus…
Alembic receives USFDA approval for Dexlansoprazole delayed-release capsules
Alembic Pharmaceuticals secures final USFDA approval for Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg,…
Lupin achieves S&P Global ESG Score of 91 for 2025, surpassing pharma industry average
Lupin reports a 91-point S&P Global ESG Score for 2025, exceeding the pharma industry average of 28 and marking a major rise…
Lupin receives EIR from U.S. FDA for Aurangabad facility
The Establishment Inspection Report follows a product-specific Pre-Approval Inspection conducted by the U.S. FDA at Lupin’s…
THSTI, Miltenyi Biotec and BIRAC launch India’s first hands-on training on cell and gene therapy…
The initiative focuses on building India’s capacity in CAR-T cell therapy through practical training and industry-academia…
Lupin manufacturing solutions commissions dedicated oncology block at Vizag facility
Lupin Manufacturing Solutions has commissioned a new high-containment oncology unit at its Vizag site to expand contract…
Novo Nordisk India reduces Wegovy prices by 37% to expand access for people
Novo Nordisk India has reduced the weekly price of the starting dose of Wegovy from INR 4,336 to INR 2,712, aiming to make…
A biosimilar boost amid trade barriers
Even as India’s biggest pharma companies pursue biosimilars, product recalls related to manufacturing defects threaten to queer…
Servier India launches biomarker testing initiative for AML and Cholangiocarcinoma patients
The programme is introduced in collaboration with MedGenome and Strand Life Sciences to expand access to molecular testing across…
Zydus receives NMPA approval in China for Venlafaxine extended-release capsules
This marks the first NMPA approval for Zydus in the Chinese market
SPDS to conduct Dissolution Science training programme for regulators in collaboration with DCGI,…
The training is scheduled for 12 November 2025 at CDSCO, Mumbai